Evidence map›Paper›PMID 21044077›Full record

ReviewJournal of neurochemistry2011

CREB: a multifaceted regulator of neuronal plasticity and protection.

Kensuke Sakamoto, Kate Karelina, Karl Obrietan

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of neurochemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 286 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
286citing papers in PubMed, 1 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

286 citing papers in PubMed, 1 synthesis or guideline pooled it, 529 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Antioxidant and Anti-Inflammatory Effects of InhaledPlants (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

226 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kensuke SakamotoDepartment of Neuroscience, Ohio State University, Columbus, Ohio 43210, USA.
Kate Karelina
Karl Obrietan
The Ohio State University · US

Funding

The ERK/MAPK Pathway and Circadian Clock EntrainmentR01MH062335 · NIMH · OHIO STATE UNIVERSITY · PI OBRIETAN, KARL H · 2002 to 2011
$2.9M
Activity-dependent microRNA expression and function in the mature nervous systemR01NS066345 · NINDS · OHIO STATE UNIVERSITY · PI IMPEY, SOREN, OBRIETAN, KARL H · 2010 to 2014
$1.9M
Mechanisms of hippocampal excitotoxic cell death and structural remodelingR01NS067409 · NINDS · OHIO STATE UNIVERSITY · PI OBRIETAN, KARL H · 2009 to 2010
$750k
NIMH NIH HHS MH62335NIMH NIH HHS R01 MH062335NINDS NIH HHS NS066345NINDS NIH HHS NS067409NINDS NIH HHS R01 NS066345NINDS NIH HHS R01 NS067409
6 · The paper itself

Abstract

Since its initial characterization over 20 years ago, there has been intense and unwavering interest in understanding the role of the transcription factor cAMP-responsive element binding protein (CREB) in nervous system physiology. Through an array of experimental approaches and model systems, researchers have begun to unravel the complex and multifaceted role of this transcription factor in such diverse processes as neurodevelopment, synaptic plasticity, and neuroprotection. Here we discuss current insights into the molecular mechanisms by which CREB couples synaptic activity to long-term changes in neuronal plasticity, which is thought to underlie learning and memory. We also discuss work showing that CREB is a critical component of the neuroprotective transcriptional network, and data indicating that CREB dysregulation contributes to an array of neuropathological conditions.

Indexed as

Neuroprotective AgentsAlzheimer DiseaseAnimalsCyclic AMP Response Element-Binding ProteinHumansMemoryNervous System DiseasesNeuronal PlasticityCREB1 protein, humanCyclic AMP Response Element-Binding ProteinNeuroprotective Agents

Identifiers

PMID21044077
PMCPMC3575743
OpenAlexW1608481794

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.